Literature DB >> 10776795

Lipopeptides as immunoadjuvants and immunostimulants in mucosal immunization.

W Baier1, N Masihi, M Huber, P Hoffmann, W G Bessler.   

Abstract

In previous studies we have shown that lipopeptides constitute potent immunoadjuvants in mice, rabbits and other species: in parenteral immunization, lipopeptide adjuvants were comparable, or in some cases superior to Freund's adjuvant, and were devoid of the side effects of this additive. Here we demonstrate that lipopeptides also constitute adjuvants for mucosal immunizations. The serum antibody responses against the wheat storage protein gliadin, the bee venom constituent melittin, or the hen egg protein ovalbumin could in most cases be enhanced more than 100-fold by the lipopeptide P3CSK4, applied via the nasal route. An enhanced specific antibody level could also be detected in supernatants of cell cultures prepared from spleens, Peyer's patches, lungs and mesenteric lymph nodes of immunized mice. Moreover, the lipopeptide P3CSK4 enhanced chemiluminescence in mouse spleen cells and peritoneal macrophages in vitro, indicating a macrophage-activating effect. Finally, nasal application of lipopeptide increased protection against a lethal infection of influenza. Our findings are of importance for the improvement of immunizations and might lead to more effective vaccines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10776795     DOI: 10.1016/s0171-2985(00)80093-5

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

Review 1.  Bacterial infectious disease control by vaccine development.

Authors:  Roy Curtiss
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  Orally administered Giardia duodenalis extracts enhance an antigen-specific antibody response.

Authors:  L A Dunn; J A Upcroft; E V Fowler; B S Matthews; P Upcroft
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Immunostimulation by the synthetic lipopeptide P3CSK4: TLR4-independent activation of the ERK1/2 signal transduction pathway in macrophages.

Authors:  M R Müller; S D Pfannes; M Ayoub; P Hoffmann; W G Bessler; K Mittenbühler
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

4.  Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response.

Authors:  Ling Mao; Chang Liu; Jing-Yi Liu; Zi-Li Jin; Zhe Jin; Ruo-Yi Xue; Rang Feng; Guo-Cheng Li; Yan Deng; Hao Cheng; Quan-Ming Zou; Hai-Bo Li
Journal:  Front Immunol       Date:  2022-03-09       Impact factor: 7.561

Review 5.  Targeting TLR2 for vaccine development.

Authors:  Afonso P Basto; Alexandre Leitão
Journal:  J Immunol Res       Date:  2014-06-26       Impact factor: 4.818

6.  Toll-like receptor 2 activators modulate oral tolerance in mice.

Authors:  M C Tunis; B Dawod; K R Carson; L L Veinotte; J S Marshall
Journal:  Clin Exp Allergy       Date:  2015-11       Impact factor: 5.018

7.  Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.

Authors:  Sarra Hamrouni; Rachel Bras-Gonçalves; Abdelhamid Kidar; Karim Aoun; Rym Chamakh-Ayari; Elodie Petitdidier; Yasmine Messaoudi; Julie Pagniez; Jean-Loup Lemesre; Amel Meddeb-Garnaoui
Journal:  PLoS Negl Trop Dis       Date:  2020-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.